ContactDictionary

Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Breast cancer, female
Trial Type:  Prevention
Results 1-25 of 25 for your search:
Start Over
Metformin Hydrochloride in Preventing Breast Cancer in Patients with Atypical Hyperplasia or In Situ Breast Cancer
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Age: 25 to 55
Trial IDs: A211102, NCI-2013-00995, CALGB-A211102, NCT01905046
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Status: Active
Phase: Phase III
Type: Prevention
Age: 18 and over
Trial IDs: CR107047, NCI-2016-00410, 2015-001630-21, 39039039STM4001, NCT02555878
Breast-Conserving Surgery and Radiation Therapy in Treating Patients with Multiple Ipsilateral Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 and over
Trial IDs: Z11102, NCI-2012-00707, ACOSOG-Z11102, CDR0000728605, NCT01556243
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Status: Active
Phase: Phase II
Type: Prevention
Age: 18 and over
Trial IDs: 368255, NCI-2015-00026, 1137008 / 20130058, NCT01570036
NSAID Effects on Clinical and Imaging Breast Biomarkers
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 75 and under
Trial IDs: 1RO1 CA1615301A1, NCI-2015-01399, 12-0080-04, 676847, NCT01761877
Metformin Hydrochloride in Reducing Obesity-Associated Breast Cancer Risk
Status: Active
Phase: Phase II
Type: Prevention
Age: 30 to 45
Trial IDs: 1300000596, NCI-2015-01211, 1300000596A024, NCT02028221
Omega-3 Fatty Acids in Preventing Recurrence in Patients with Hormone Receptor-Negative or HER2-Positive Stage 0-III Breast Cancer That Have Completed Treatment
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: OSU-13130/2013C0068, NCI-2014-02036, 2013C0068, OSU-13130, NCT02295059
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
Status: Active
Phase: Phase II
Type: Prevention
Age: 18 and over
Trial IDs: 2014-0443, NCI-2015-00033, NCT02297698
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: NCI2013-01-03, NCI-2014-02412, HHSN2612201200035I, N01-CN-2012-00035, NWU2013-01-03, NCT02314156
Community Hospital Identification with MRI and Echocardiography in Detecting Chemotherapy-related Cardiotoxicity in Patients with Stage I-III Breast Cancer or Lymphoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 21 and over
Trial IDs: 01115, NCI-2015-01516, WF 01115, NCT02566109
Conjugated Estrogens/Bazedoxifene in Reducing Benign Breast Tissue Proliferation and Menopausal Symptoms in Peri or Post-Menopausal Patients at Moderate Risk for Breast Cancer
Status: Active
Phase: Phase II
Type: Prevention
Age: 60 and under
Trial IDs: STUDY00002440, NCI-2016-00902, NCT02729701
Sirolimus in Preventing Invasive Breast Cancer in Patients with Ductal Carcinoma In Situ or Atypical Ductal Breast Hyperplasia
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 51 to 80
Trial IDs: CTMS# 15-2096, NCI-2016-01112, HSC20150556H, NCT02642094
Afimoxifene in Reducing the Risk of Breast Cancer in Women with Mammographically Dense Breast
Status: Not yet active
Phase: Phase II
Type: Prevention
Age: 40 to 55
Trial IDs: MDA2016-07-02, NCI-2017-00244, N01-CN-2012-00034, NCT03063619
Alendronate Sodium in Preventing Breast Cancer in Premenopausal Patients Undergoing Risk-Reduction Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: UW13060, NCI-2016-00786, 2016-0322, NCT02781805
Vaccine Therapy in Preventing Cancer Recurrence in Patients with Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
Status: Active
Phase: Phase I
Type: Prevention, Treatment
Age: 18 and over
Trial IDs: UWI4090, NCI-2016-00581, 9626, N01-CN-2012-00033, UWI2014-03-01, NCT02780401
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 75
Trial IDs: IUCRO-0365, NCI-2013-00422, NCT01793948
Curcumin in Reducing Inflammatory Changes in Breast Tissue in Obese Patients At High Risk for Breast Cancer
Status: Active
Phase: No phase specified
Type: Prevention
Age: 19 and over
Trial IDs: OSU-13034, NCI-2013-01199, 2013C0039, NCT01975363
Exercise Intervention in Preventing Breast Cancer in African-American Patients With Metabolic Syndrome
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 45 to 65
Trial IDs: 2012-012, NCI-2013-01701, NCT02103140
Video Game-Based Exercise Program in Increasing Fitness and Decreasing BMI in African American Women
Status: Active
Phase: No phase specified
Type: Prevention
Age: 40 to 59
Trial IDs: PRO00000116, NCI-2013-01720, CR00001302, NCT02152462
Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema
Status: Active
Phase: No phase specified
Type: Prevention
Age: 18 and over
Trial IDs: VICCBRE1438, NCI-2014-01427, NCT02167659
Energy Balance Interventions in Increasing Physical Activity in BRCA-Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
Status: Active
Phase: No phase specified
Type: Prevention
Age: 18 and over
Trial IDs: 2014-0230, NCI-2015-00095, NCT02194387
Aerobic Exercise Training in Lowering the Risk of Breast Cancer in Patients at High-Risk for Development of Breast Cancer
Status: Active
Phase: No phase specified
Type: Prevention
Age: 46 and over
Trial IDs: 15-093, NCI-2016-01776, NCT02494869
High-Intensity Interval Training or Moderate-Intensity Continuous Training in Preventing Breast Cancer in High Risk Patients
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: 2016-0442, NCI-2016-01938, NCT02923401
Addressing Modifiable Breast Cancer Risk Factors with Project CONECT
Status: Active
Phase: No phase specified
Type: Prevention
Age: 40 to 65
Trial IDs: MCC-16-12892, NCI-2017-00561, NCT02871388
Apigenin in Increasing Health Benefits in High Risk Breast Clinic Patients
Status: Not yet active
Phase: No phase specified
Type: Prevention, Supportive care
Age: 18 and over
Trial IDs: OSU-17006, NCI-2017-00517, 2017C0051, NCT03139227
Start Over